Family-based Telemedicine vs. Inpatient Anorexia Nervosa Treatment (FIAT)

Family-based Telemedicine vs. Inpatient Anorexia Nervosa Treatment (FIAT)

The FIAT study is funded by the Innovationsfonds of the German Ministry of Health via the DLR Project Management Agency. The study will be conducted in up to 21 hospitals across Germany and in collaboration with 10 German public health insurance companies. The primary aim of this study is to compare Family-Based Treatment delivered via telehealth (FBT) with inpatient multimodal therapy (IMT) with respect to treatment outcomes and health economic data. The results of the study will serve as a basis for the decision on the inclusion of FBT in the German S3 guidelines and the future reimbursement of FBT by public health insurances in Germany.

Inclusion Criteria:

• restrictive and bulimic subtypes of anorexia nervosa (ICD-10: F50.00; F50.01)
• inpatient treatment indication according to S3 guideline
• weight < 3. BMI-percentile or
• weight <10. percentile and psychiatric comorbidity/rapid weight loss/lack of weight gain during outpatient treatment over last three month
• planned inpatient treatment
• insured with one of the participating health insurance companies
• stable internet connection

Exclusion Criteria:

• weight <67%mBMI
• acute self harm or danger to others
• acute psychosis or suicidal tendencies
• current substance abuse
• child abuse or domestic violence in the family
• insured with other health insurance company
• judicial placement order for inpatient treatment
• known, currently existing child protection problems or proceedings by the family court